CoChat
Sign Up
Cited by 113Connective tissue disorders researchDermatological and Skeletal DisordersCerebrovascular and genetic disorders

The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.

Vascular aspects of the Ehlers-Danlos Syndromes

Malfait, Fransiska·2018·Matrix Biology
DOI 10.1016/j.matbio.2018.04.013
Open this paper in CoChat — free account

Abstract

The Ehlers-Danlos Syndromes comprise a heterogeneous group of rare monogenic conditions that are characterized by joint hypermobility, skin and vascular fragility and generalized connective tissue friability. The latest classification recognizes 13 clinical subtypes, with mutations identified in 19 different genes. Besides defects in fibrillar collagens (collagen types I, III and V), their modifying enzymes (ADAMTS-2, lysylhydroxylase 1 (LH1)), and molecules involved in collagen folding (FKBP22), defects have recently been identified in other constituents of the extracellular matrix (e.g. Tenascin-X, collagen type XII), enzymes involved in glycosaminoglycan biosynthesis (β4GalT7 and β3GalT6), dermatan 4-O-sulfotransferase-1 (D4ST1), dermatan sulfate epimerase (DSE)), (putative) transcription factors (ZNF469, PRDM5), components of the complement pathway (C1r, C1s) and an intracellular Zinc transporter (ZIP13). Easy bruising is, to a variable degree, present in all subtypes of EDS. A variable bleeding tendency, manifesting e.g. as gum bleeding, menometrorraghia, postnatal or peri-operative hemorrhage is observed in many EDS-patients of varying EDS subtypes. Life-threatening arterial aneurysms, dissections and ruptures of medium-sized and large arteries are a hallmark of the vascular subtype of EDS, caused by a molecular defect in collagen type III, an important constituent of blood vessel walls and hollow organs. They may however also occur in other EDS subtypes, especially in classical EDS, caused by defects in type V collagen or, rarely, type I collagen, and in kyphoscoliotic EDS, caused by defects in LH1 or FKBP22. These manifestations of vascular fragility and bleeding are usually attributed to fragility of the blood vessel walls and the perivascular connective tissues, but the molecular pathomechanisms underlying these complications are poorly studied. This review summarizes current knowledge on manifestations of vascular fragility in the different EDS subtypes.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.matbio.2018.04.013

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 128 references

Research works printed but not linked: 2

  1. Beighton, 1998, Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK), Am. J. Med. Genet., 77, 31, 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O · DOI · Paper page
  2. Malfait, 2007, Three arginine to cysteine substitutions 4 in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood, Hum. Mutat., 28, 387, 10.1002/humu.20455 · DOI · Paper page

Cited by

Sorted by citations

Items 101–112 of 112

Related

See all

Metadata

Authors
Malfait, F.
Affiliations
Ghent University Hospital (BE)
Corresponding author
Malfait, Fransiska
ORCID
Malfait, Fransiska
Venue
Matrix Biology
Publisher
Elsevier BV
Published
2018-10
Volume
71-72
Pages
380-395
ISSN
0945-053X (ISSN-L)
DOI
10.1016/j.matbio.2018.04.013
OpenAlex
W2800944293
Cited by
113
References
128
Citations by year
2026: 8 · 2025: 11 · 2024: 15 · 2023: 12 · 2022: 10 · 2021: 14 · 2020: 22 · 2019: 19 · 2018: 2
FWCI
2.00
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Matrix Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Funders
Vlaamse regering
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
Keywords
Ehlers-Danlos syndrome, vascular fragility, arterial aneurysm, arterial dissection, arterial rupture, bleeding tendency, easy bruising, type III collagen, type V collagen, connective tissue diseases, glycosaminoglycan synthesis
MeSH terms
Collagen, Ehlers-Danlos Syndrome, Extracellular Matrix, Humans, Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase, Mutation, Vascular Diseases, Genetic Predisposition to Disease, Tacrolimus Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review